Myeloma treatment at Centro Médico Teknon

Myeloma treatment at Centro Médico Teknon in Barcelona, Spain includes various diagnostic and therapy options. A diagnostic consultation with Dr. Cobo may cost around €565-€625, while a bone marrow biopsy is typically around €1,800-€2,700. Treatment courses like chemotherapy run from €2,500-€3,500. The clinic is part of the Quirónsalud group and holds JCI accreditation for its international standards.

The program is led by Dr. Francesc Cobo Valien. He is an MD, PhD hematologist and oncologist with 26 years of experience. Dr. Cobo has performed over 1,100 procedures. His qualifications include a doctorate from the University of Barcelona. He is an author of scientific publications in his field.

Myeloma Diagnostics at Teknon

The diagnostic process begins with a specialist consultation. A comprehensive evaluation follows. It includes key laboratory and imaging tests:

• Complete blood count and biochemical analysis (€100-€328)
• CT scan (around €756-€814)
• Bone marrow biopsy (€1,800-€2,700)
• 24-hour urine protein electrophoresis (€450-€700)
• Additional immunological studies are available if needed.

Available Myeloma Treatments

The clinic offers a range of systemic and advanced therapies. The choice depends on the individual case and disease stage.

• Chemotherapy: This is a standard systemic treatment. It involves intravenous drug administration over multiple courses to target myeloma cells.
• Talquetamab (Talvey): This is a newer targeted biologic therapy. It is a subcutaneous bispecific antibody. It offers a novel approach and is typically an outpatient treatment.
• CAR-T Cell Therapy: This is a personalized immunotherapy for refractory cases. A full treatment program for CAR-T therapy starts at around €350,000. It includes complete evaluation, hospitalization, and post-procedure monitoring.
• Stem Cell Transplant: Both autologous and allogeneic bone marrow transplants are available. This procedure aims to restore healthy blood production.

Patients receive care in a JCI-accredited facility with a 4.7 patient rating. To explore these myeloma treatment options, you can request a consultation to discuss a personalized plan.